Catalyst
Slingshot members are tracking this event:
If the Phase 1/2 study results of ALN-CC5 are positive, Alnylam expects to initiate a Phase 3 trial in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
http://investors.alnylam.com/releasedetail.cfm?ReleaseID=1002720
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1/2 Study, Phase 3, Initiation
